Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude Commences Simultaneous Epic HF, Atlas+ HF CRT-D Launches

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical's entry into the cardiac resynchronization therapy (CRT) market will be supported by a 20% sales force expansion, from roughly 1,000 to 1,200 people this year
Advertisement

Related Content

St. Jude Credits Soaring ICD Sales To Its Product Line, Not Guidant Recall
St. Jude Credits Soaring ICD Sales To Its Product Line, Not Guidant Recall
Medtronic ICD Growth Rate Hiccups On “Trialing” Of St. Jude Epic
Medtronic ICD Growth Rate Hiccups On “Trialing” Of St. Jude Epic
Medtronic, St. Jude Will Not Take CRT Market Share, Guidant Vows
Medtronic, St. Jude Will Not Take CRT Market Share, Guidant Vows
Advertisement
UsernamePublicRestriction

Register

MT020518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel